Find clinical trials for Heart Disease in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Warszawa, Mazowieckie, POL:
The purpose is to compare median two-year clinical outcome after OCT guided vs. standard guided revascularization of patients requiring complex bifur...
Warsaw, Poland and 37 other locations
The purpose is to investigate if a strategy of routine OCT based diagnosis and guidance of PCI improves clinical outcomes compared with a standard st...
Warsaw, Poland and 18 other locations
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardia...
Phase 2
Warsaw, Masovian Voivodeship, Poland and 40 other locations
Multi-center, prospective, randomized controlled study comparing PCI guided by angiography versus iFR Co-Registration using commercially available Ph...
Warsaw, Poland and 83 other locations
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Warsaw, Poland and 163 other locations
TripleTRE investigates the effect of initial triple combination therapy (oral endothelin receptor antagonist (ERA) + oral phosphodiesterase tyüe-5 in...
Phase 4
Otwock, Poland and 18 other locations
with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation...
Phase 3
Warsaw, Poland and 554 other locations
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...
Phase 3
Warsaw, Poland and 764 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Warsaw, Masovian Province, Poland and 623 other locations
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Warsaw, Poland and 742 other locations
Clinical trials
Research sites
Resources
Legal